Bio-Techne Corporation (TECH)

NASDAQ: TECH · IEX Real-Time Price · USD
73.85
+1.29 (1.78%)
At close: Mar 21, 2023, 4:00 PM
73.84
-0.01 (-0.01%)
After-hours: Mar 21, 2023, 4:05 PM EDT
1.78%
Market Cap 11.61B
Revenue (ttm) 1.12B
Net Income (ttm) 261.82M
Shares Out 157.28M
EPS (ttm) 1.61
PE Ratio 45.66
Forward PE 42.19
Dividend $0.32 (0.43%)
Ex-Dividend Date Feb 10, 2023
Volume 603,725
Open 73.05
Previous Close 72.56
Day's Range 72.66 - 74.04
52-Week Range 68.00 - 113.81
Beta 1.24
Analysts Buy
Price Target 103.14 (+39.66%)
Earnings Date May 3, 2023

About TECH

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cel... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Feb 9, 1989
Employees 3,000
Stock Exchange NASDAQ
Ticker Symbol TECH
Full Company Profile

Financial Performance

In 2022, Bio-Techne's revenue was $1.11 billion, an increase of 18.75% compared to the previous year's $931.03 million. Earnings were $272.05 million, an increase of 93.75%.

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for TECH stock is "Buy." The 12-month stock price forecast is $103.14, which is an increase of 39.66% from the latest price.

Price Target
$103.14
(39.66% upside)
Analyst Consensus: Buy
Stock Forecasts

News

BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM

MINNEAPOLIS , March 15, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its participation in the Cell and Gene Therapy Catapult Process Analytical Technolog...

6 days ago - PRNewsWire

BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE

MINNEAPOLIS , March 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Barclays G...

1 week ago - PRNewsWire

BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF

MINNEAPOLIS , March 1, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced Wilson Wolf Manufacturing has met the trailing 12-month earnings before interest, taxes, depreciation, ...

2 weeks ago - PRNewsWire

BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE

MINNEAPOLIS , Feb. 28, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Cowen 43rd Annual Healt...

3 weeks ago - PRNewsWire

ExoDx PROSTATE TEST GRANTED EXPANDED COVERAGE BY MEDICARE

Medicare contractor National Government Services finalizes local coverage determination for biomarker testing related to prostate cancer to include repeat biopsies and yearly testing MINNEAPOLIS , Feb...

3 weeks ago - PRNewsWire

BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE

MINNEAPOLIS , Feb. 22, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Citi 2023 H...

3 weeks ago - PRNewsWire

BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES

MINNEAPOLIS , Feb. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cell Signaling Technology ( CST) announced today the addition of Simple Western™ validation to CST antibodies. Th...

1 month ago - PRNewsWire

Techne (TECH) Q2 Earnings and Revenues Miss Estimates

Techne (TECH) delivered earnings and revenue surprises of -4.08% and 6.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

BIO-TECHNE DECLARES DIVIDEND

MINNEAPOLIS , Feb. 2, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 3...

1 month ago - PRNewsWire

BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS

MINNEAPOLIS , Feb. 2, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022. Second Quarter FY2023 Highlights S...

1 month ago - PRNewsWire

BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL

MINNEAPOLIS , Jan. 31, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced Shane Bohnen has been appointed Senior Vice President, General Counsel effective March 3, 2023.  Mr. B...

1 month ago - PRNewsWire

5 Cheapest Health Care Stocks You Should Think About

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: ABBVFATETHRD
1 month ago - Benzinga

Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

BIO-TECHNE LAUNCHES THE MauriceFlex™ SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS

MINNEAPOLIS , Jan. 26, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of its ProteinSimple-branded MauriceFlex™ during the WCBP conference in Washington D.C. Mau...

1 month ago - PRNewsWire

5 Health Care Stocks That Are Diving - And May Rally

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: FATEIPSCNVOSSNPX
2 months ago - Benzinga

BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS

MINNEAPOLIS, Jan. 17, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, February 2, 2023, at 8:00 a.m. CST...

2 months ago - PRNewsWire

REGN or TECH: Which Is the Better Value Stock Right Now?

REGN vs. TECH: Which Stock Is the Better Value Option?

Other symbols: REGN
2 months ago - Zacks Investment Research

BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT

An integrated assay using proprietary RNAscope ™ and miRNAscope ™ technologies to measure the biodistribution and function of novel gene therapies and endogenous regulatory RNAs. MINNEAPOLIS , Jan. 10...

2 months ago - PRNewsWire

GSK or TECH: Which Is the Better Value Stock Right Now?

GSK vs. TECH: Which Stock Is the Better Value Option?

Other symbols: GSK
3 months ago - Zacks Investment Research

BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

MINNEAPOLIS , Dec. 21, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan...

3 months ago - PRNewsWire

Our 7 Top Biotech Stock Picks for 2023

If there's a silver lining regarding the coronavirus pandemic, it's that it demonstrated the importance of the top biotech stock picks for 2023. While medical innovations may seem frustratingly slow, ...

3 months ago - InvestorPlace

BIIB vs. TECH: Which Stock Is the Better Value Option?

BIIB vs. TECH: Which Stock Is the Better Value Option?

Other symbols: BIIB
3 months ago - Zacks Investment Research

BIO-TECHNE RELEASES MITOBRILLIANT™ FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS

MINNEAPOLIS, Dec. 5, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the introduction of MitoBrilliant™ probes.  These novel probes enable the fluorescent labeling and track...

3 months ago - PRNewsWire

Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market

New collaboration will develop assays that offer a streamlined workflow for analysing even the most challenging genes. MINNEAPOLIS , Dec. 1, 2022 /PRNewswire/ -- Asuragen, a Bio-Techne brand (NASDAQ: ...

3 months ago - PRNewsWire

BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE

MINNEAPOLIS , Nov. 28, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Fifth Annual Evercore I...

4 months ago - PRNewsWire